To compare the effectiveness of cabergoline and medroxyprogesterone acetate in the treatment of uterine adenomyosis
Phase 4
- Conditions
- Health Condition 1: N719- Inflammatory disease of uterus, unspecified
- Registration Number
- CTRI/2020/04/024422
- Lead Sponsor
- SRM College of Pharmacy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)age between 18-50 with complaints of chronic pelvic pain
2)USG suggestive of Adenomyosis
3)consenting to participate in the study
4) use of barrier contraception or sexual abstinence during study period.
Exclusion Criteria
1) Women attempting pregnancy or currently pregnant
2) less than six months postpartum
3)lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method